{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:36:38Z","timestamp":1782999398622,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.autrev.2025.103759","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:30:57Z","timestamp":1738024257000},"page":"103759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications"],"prefix":"10.1016","volume":"24","author":[{"given":"Pooria","family":"Fazeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Karamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Hajivalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Daryabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Panji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103759_bb0005","article-title":"The role of T cell receptor signaling in the development of type 1 diabetes","volume":"11","author":"Clark","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0010","first-page":"13","article-title":"Current understandings of the pathogenesis of type 1 diabetes: genetics to environment","volume":"11","author":"Giwa","year":"2020"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0015","first-page":"879","article-title":"The evolving landscape of autoantigen discovery and characterization in type 1 diabetes","volume":"68","author":"Purcell","year":"2019"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0020","first-page":"719","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0025","first-page":"51","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103759_bb0035","first-page":"4264","article-title":"Antiislet autoantibodies usually develop sequentially rather than simultaneously","volume":"81","author":"Yu","year":"1996"},{"key":"10.1016\/j.autrev.2025.103759_bb0040","doi-asserted-by":"crossref","unstructured":"Colli ML, Szymczak F, Eizirik DLJFie. Molecular footprints of the immune assault on pancreatic beta cells in type 1 diabetes. 2020:666.","DOI":"10.3389\/fendo.2020.568446"},{"issue":"suppl_2","key":"10.1016\/j.autrev.2025.103759_bb0045","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic \u03b2-cell death in type 1 and type 2 diabetes: many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2025.103759_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","article-title":"Memory T cells and vaccines","volume":"21","author":"Esser","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smim.2016.02.001","article-title":"Role of memory T cell subsets for adoptive immunotherapy","volume":"28","author":"Busch","year":"2016","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0065","first-page":"90","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016"},{"key":"10.1016\/j.autrev.2025.103759_bb0070","first-page":"16","article-title":"Memory T follicular helper CD4 T cells","volume":"6","author":"Hale","year":"2015"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0075","first-page":"936","article-title":"Detection and characterization of CD8+ autoreactive memory stem T cells in patients with type 1 diabetes","volume":"67","author":"Vignali","year":"2018"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0080","first-page":"133","article-title":"Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes","volume":"273","author":"\u00d6ling","year":"2012"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0085","first-page":"113","article-title":"Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus","volume":"9","author":"Monti","year":"2009"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0090","first-page":"480","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020"},{"key":"10.1016\/j.autrev.2025.103759_bb0095","first-page":"494","article-title":"Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient","volume":"52","author":"Velthuis","year":"2009"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0100","first-page":"2267","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"The lancet Diabetes & endocrinology"},{"issue":"8","key":"10.1016\/j.autrev.2025.103759_bb0110","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.autrev.2025.103759_bb0120","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","article-title":"Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines","volume":"101","author":"Geginat","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0125","article-title":"The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes","volume":"10","author":"Fazeli","year":"2022"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0130","first-page":"1285","article-title":"HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus","volume":"26","author":"Roep","year":"1996"},{"issue":"12","key":"10.1016\/j.autrev.2025.103759_bb0135","first-page":"3051","article-title":"Increased effector memory insulin-specific CD4+ T cells correlate with insulin autoantibodies in patients with recent-onset type 1 diabetes","volume":"66","author":"Spanier","year":"2017"},{"key":"10.1016\/j.autrev.2025.103759_bb0140","first-page":"1239","article-title":"Decreased expression of programmed death-1 on CD8+ effector memory T lymphocytes correlates with the pathogenesis of type 1 diabetes","volume":"58","author":"Shan","year":"2021"},{"key":"10.1016\/j.autrev.2025.103759_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.04.012","article-title":"A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes","volume":"166-167","author":"Moya","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103759_bb0150","first-page":"781","article-title":"IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients","volume":"58","author":"Ferreira","year":"2015"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0155","article-title":"CD4+ CD25+ CD127hi cell frequency predicts disease progression in type 1 diabetes","volume":"6","author":"Narsale","year":"2021"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)01139-X","article-title":"Molecular and functional profiling of memory CD8 T cell differentiation","volume":"111","author":"Kaech","year":"2002","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.autrev.2025.103759_bb0165","first-page":"3460","article-title":"Autoreactive T effector memory differentiation mirrors \u03b2 cell function in type 1 diabetes","volume":"128","author":"Yeo","year":"2018"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0170","first-page":"418","article-title":"Characterization of resident lymphocytes in human pancreatic islets","volume":"187","author":"Radenkovic","year":"2017"},{"key":"10.1016\/j.autrev.2025.103759_bb0175","first-page":"67","article-title":"Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state","volume":"181","author":"Schwedhelm","year":"2017"},{"key":"10.1016\/j.autrev.2025.103759_bb0180","first-page":"2547","article-title":"Phenotypic analysis of human lymph nodes in subjects with new-onset type 1 diabetes and healthy individuals by flow cytometry","volume":"10","author":"Yang","year":"2019"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0190","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0195","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/JLB.5MR0321-145R","article-title":"Stem cell-like memory T cells: the generation and application","volume":"110","author":"Wang","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0200","first-page":"303","article-title":"Asymmetric T cell division of GAD65 specific naive T cells contribute to an early divergence in the differentiation fate into memory T cell subsets","volume":"167","author":"Alampi","year":"2022"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0205","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni.1718","article-title":"Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus","volume":"10","author":"Gebhardt","year":"2009","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103759_bb0210","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ni.2745","article-title":"Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells","volume":"14","author":"Skon","year":"2013","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103759_bb0215","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.4049\/jimmunol.1201305","article-title":"The molecular signature of tissue resident memory CD8 T cells isolated from the brain","volume":"189","author":"Wakim","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0220","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.autrev.2025.103759_bb0225","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.1202288109","article-title":"Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation","volume":"109","author":"Mackay","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0230","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.4049\/jimmunol.1200402","article-title":"Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues","volume":"188","author":"Casey","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0235","first-page":"572","article-title":"Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes","volume":"192","author":"Chee","year":"2014"},{"issue":"18","key":"10.1016\/j.autrev.2025.103759_bb0240","first-page":"2623","article-title":"Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis","volume":"23","author":"Stojanovic","year":"2017"},{"key":"10.1016\/j.autrev.2025.103759_bb0245","first-page":"2180","article-title":"CD226 deletion reduces type 1 diabetes in the NOD mouse by impairing thymocyte development and peripheral T cell activation","volume":"11","author":"Shapiro","year":"2020"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0250","first-page":"581","article-title":"Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes","volume":"187","author":"Kuric","year":"2017"},{"issue":"7","key":"10.1016\/j.autrev.2025.103759_bb0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni1472","article-title":"Lymphoid reservoirs of antigen-specific memory T helper cells","volume":"8","author":"Fazilleau","year":"2007","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0260","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+ CXCR3\u2212 CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103759_bb0265","first-page":"6","article-title":"Memory T follicular helper CD4 T cells","author":"Hale","year":"2015","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103759_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134523","article-title":"Circulating CCR7+ICOS+ memory T follicular helper cells in patients with multiple sclerosis","volume":"10","author":"Fan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103759_bb0275","first-page":"1294","article-title":"Germinal centre frequency is decreased in pancreatic lymph nodes from individuals with recent-onset type 1 diabetes","volume":"60","author":"Willcox","year":"2017"},{"issue":"11","key":"10.1016\/j.autrev.2025.103759_bb0280","first-page":"712","article-title":"B cells in type 1 diabetes mellitus and diabetic kidney disease","volume":"13","author":"Smith","year":"2017"},{"issue":"11","key":"10.1016\/j.autrev.2025.103759_bb0285","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0290","article-title":"B cell helper T cells and type 1 diabetes","volume":"92","author":"Vandamme","year":"2020"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2337\/db16-0714","article-title":"Circulating CXCR5+PD-1+ICOS+ follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies","volume":"66","author":"Viisanen","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0300","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-015-3509-8","article-title":"IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients","volume":"58","author":"Ferreira","year":"2015","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.autrev.2025.103759_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079858","article-title":"Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes","volume":"8","author":"Xu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103759_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104520","article-title":"Expanding scope of TEMRA in autoimmunity","volume":"90","author":"Perl","year":"2023","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13067","article-title":"Mitochondrial mass governs the extent of human T cell senescence","volume":"19","author":"Callender","year":"2020","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/biology12040597","article-title":"Mitochondrial dysfunction in CD4+ T effector memory RA+ cells","volume":"12","author":"Strickland","year":"2023","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0325","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/s41467-017-01728-5","article-title":"Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA","volume":"8","author":"Tian","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","article-title":"Once a Treg, always a Treg?","volume":"259","author":"Sawant","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2025.103759_bb0335","article-title":"Regulatory T cell function in autoimmune disease","volume":"4","author":"Rajendeeran","year":"2021","journal-title":"Journal of translational autoimmunity"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/cells11101687","article-title":"The regulatory-T-cell memory phenotype: what we know","volume":"11","author":"Khantakova","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0350","first-page":"440","article-title":"Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients","volume":"11","author":"Jin","year":"2019"},{"key":"10.1016\/j.autrev.2025.103759_bb0355","doi-asserted-by":"crossref","unstructured":"Boldison J, Long AE, Aitken RJ, Wilson IV, Megson C, Hanna SJ, et al. Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes. 2022:1\u201313.","DOI":"10.1007\/s00125-021-05595-0"},{"issue":"7","key":"10.1016\/j.autrev.2025.103759_bb0360","first-page":"3918","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011"},{"issue":"9","key":"10.1016\/j.autrev.2025.103759_bb0365","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00592-021-01711-z","article-title":"Decreased expression of programmed death-1 on CD8(+) effector memory T lymphocytes correlates with the pathogenesis of type 1 diabetes","volume":"58","author":"Shan","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.autrev.2025.103759_bb0370","first-page":"72","article-title":"A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes","volume":"166","author":"Moya","year":"2016"},{"key":"10.1016\/j.autrev.2025.103759_bb0375","series-title":"Adult type 1 diabetes patients have a higher frequency of CD107a memory CD8 T cells: It\u00e4-Suomen yliopisto","author":"Stevens","year":"2022"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0380","first-page":"437","article-title":"Circulating CXCR5+ PD-1+ ICOS+ follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies","volume":"66","author":"Viisanen","year":"2017"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0385","first-page":"578","article-title":"Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes","volume":"21","author":"Abdelsamed","year":"2020"},{"key":"10.1016\/j.autrev.2025.103759_bb0390","article-title":"New insights into the role of autoreactive CD8 T cells and cytokines in human type 1 diabetes","volume":"11","author":"Bender","year":"2021"},{"key":"10.1016\/j.autrev.2025.103759_bb0395","series-title":"Vives-Pi MJTiE, Metabolism. Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus","author":"Gomez-Mu\u00f1oz","year":"2023"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0400","first-page":"887","article-title":"Epigenetic changes induced by maternal factors during fetal life: Implication for type 1 diabetes","volume":"12","author":"Barchetta","year":"2021"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0405","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0410","first-page":"38","article-title":"Memories that last: Dynamics of memory T cells throughout the body","volume":"316","author":"Derksen","year":"2023"},{"key":"10.1016\/j.autrev.2025.103759_bb0415","article-title":"New developments in T cell immunometabolism and therapeutic implications for type 1 diabetes","volume":"13","author":"Zhang","year":"2022"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0420","first-page":"3300","article-title":"Type I diabetes pathoetiology and pathophysiology: Roles of the gut microbiome, pancreatic cellular interactions, and the \u2018bystander\u2019activation of memory CD8+ T cells","volume":"24","author":"GJIJoMS","year":"2023"},{"issue":"8499","key":"10.1016\/j.autrev.2025.103759_bb0425","first-page":"119","article-title":"Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: results of a multicentre double-blind trial","volume":"328","author":"Feutren","year":"1986"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0430","first-page":"779","article-title":"Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes","volume":"38","author":"Cook","year":"1989"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0435","first-page":"241","article-title":"Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus","volume":"85","author":"Chase","year":"1990"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0440","first-page":"710","article-title":"Immune therapies of autoimmune diseases: are we approaching a real cure?","volume":"18","author":"LJCoii","year":"2006"},{"issue":"22","key":"10.1016\/j.autrev.2025.103759_bb0445","first-page":"2143","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009"},{"issue":"9789","key":"10.1016\/j.autrev.2025.103759_bb0450","first-page":"412","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011"},{"issue":"25","key":"10.1016\/j.autrev.2025.103759_bb0455","first-page":"2598","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005"},{"issue":"9790","key":"10.1016\/j.autrev.2025.103759_bb0460","first-page":"487","article-title":"Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011"},{"issue":"11","key":"10.1016\/j.autrev.2025.103759_bb0465","first-page":"3766","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders","volume":"62","author":"Herold","year":"2013"},{"issue":"9881","key":"10.1016\/j.autrev.2025.103759_bb0470","first-page":"1905","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0475","first-page":"295","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013"},{"key":"10.1016\/j.autrev.2025.103759_bb0480","first-page":"48","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015"},{"key":"10.1016\/j.autrev.2025.103759_bb0485","first-page":"1808","article-title":"Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I\/II randomised, double-blind, placebo-controlled, dose-finding study","volume":"63","author":"Rosenzwajg","year":"2020"},{"key":"10.1016\/j.autrev.2025.103759_bb0490","article-title":"Double-edged sword: interleukin-2 promotes T regulatory cell differentiation but also expands interleukin-13-and interferon-\u03b3-producing CD8+ T Cells via STAT6-GATA-3 axis in systemic lupus erythematosus","volume":"12","author":"Kato","year":"2021"},{"issue":"18","key":"10.1016\/j.autrev.2025.103759_bb0495","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0500","first-page":"57","article-title":"reviews gf. CXCR3, CXCL10 and type 1 diabetes","volume":"25","author":"Antonelli","year":"2014"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0505","first-page":"eaai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016"},{"issue":"402","key":"10.1016\/j.autrev.2025.103759_bb0510","first-page":"eaaf7779","article-title":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes","volume":"9","author":"Alhadj Ali","year":"2017"},{"issue":"7","key":"10.1016\/j.autrev.2025.103759_bb0515","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nm.1993","article-title":"Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates","volume":"15","author":"Weaver","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103759_bb0520","first-page":"1","article-title":"Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis","volume":"5","author":"Chamian","year":"2007"},{"issue":"8","key":"10.1016\/j.autrev.2025.103759_bb0525","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2016","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0530","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142680","article-title":"Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects","volume":"6","author":"Diggins","year":"2021","journal-title":"JCI insight"},{"issue":"21","key":"10.1016\/j.autrev.2025.103759_bb0535","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167881","article-title":"Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes","volume":"8","author":"Balmas","year":"2023","journal-title":"JCI Insight."},{"key":"10.1016\/j.autrev.2025.103759_bb0540","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00125-018-4786-9","article-title":"Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis","volume":"62","author":"Perdigoto","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2025.103759_bb0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cellimm.2017.07.007","article-title":"Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes","volume":"319","author":"Long","year":"2017","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103759_bb0550","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12729","article-title":"Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity","volume":"151","author":"Wallberg","year":"2017","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0555","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-023-01847-y","article-title":"Teplizumab: First Approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.autrev.2025.103759_bb0560","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc23-0675","article-title":"Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves \u03b2-cell function","volume":"46","author":"Herold","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.autrev.2025.103759_bb0565","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0570","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"issue":"583","key":"10.1016\/j.autrev.2025.103759_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.autrev.2025.103759_bb0580","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.4049\/jimmunol.1901439","article-title":"Costimulation blockade disrupts CD4+ T cell memory pathways and uncouples their link to decline in \u03b2-cell function in type 1 diabetes","volume":"204","author":"Eichmann","year":"2020","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0585","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked","volume":"46","author":"Russell","year":"2023","journal-title":"Controlled Trial Diabetes Care"},{"key":"10.1016\/j.autrev.2025.103759_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564921","article-title":"Glutamic acid decarboxylase injection into lymph nodes: beta cell function and immune responses in recent onset type 1 diabetes patients","volume":"11","author":"Casas","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103759_bb0595","article-title":"Intralymphatic GAD-alum injection modulates B cell response and induces follicular helper T cells and PD-1+ CD8+ T cells in patients with recent-onset type 1 diabetes","volume":"12","author":"Barcenilla","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0600","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2337\/db19-0057","article-title":"Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA(1c), and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data","volume":"68","author":"Haller","year":"2019","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.autrev.2025.103759_bb0605","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161812","article-title":"Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes","volume":"8","author":"Jacobsen","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.autrev.2025.103759_bb0610","first-page":"284","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013"},{"issue":"8","key":"10.1016\/j.autrev.2025.103759_bb0615","first-page":"3285","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2016"},{"key":"10.1016\/j.autrev.2025.103759_bb0620","first-page":"3","article-title":"Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes","volume":"319","author":"Long","year":"2017"},{"key":"10.1016\/j.autrev.2025.103759_bb0625","first-page":"655","article-title":"Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis","volume":"62","author":"Perdigoto","year":"2019"},{"issue":"6","key":"10.1016\/j.autrev.2025.103759_bb0630","first-page":"1267","article-title":"Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data","volume":"68","author":"Haller","year":"2019"},{"issue":"12","key":"10.1016\/j.autrev.2025.103759_bb0635","first-page":"3129","article-title":"Costimulation blockade disrupts CD4+ T cell memory pathways and uncouples their link to decline in \u03b2-cell function in type 1 diabetes","volume":"204","author":"Eichmann","year":"2020"},{"key":"10.1016\/j.autrev.2025.103759_bb0640","article-title":"Glutamic acid decarboxylase injection into lymph nodes: beta cell function and immune responses in recent onset type 1 diabetes patients","volume":"11","author":"Casas","year":"2020"},{"issue":"3","key":"10.1016\/j.autrev.2025.103759_bb0645","article-title":"Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects","volume":"6","author":"Diggins","year":"2021"},{"key":"10.1016\/j.autrev.2025.103759_bb0650","article-title":"Intralymphatic GAD-alum injection modulates b cell response and induces follicular helper T cells and PD-1+ CD8+ T cells in patients with recent-onset type 1 diabetes","volume":"12","author":"Barcenilla","year":"2022"},{"issue":"5","key":"10.1016\/j.autrev.2025.103759_bb0655","first-page":"1005","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023"},{"issue":"16","key":"10.1016\/j.autrev.2025.103759_bb0660","article-title":"Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes","volume":"8","author":"Jacobsen","year":"2023"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T13:37:09Z","timestamp":1740922629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1568997225000199"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103759","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103759"}}